Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose

The objective of this study was to examine the effect of renal sodium–glucose cotransporter inhibition with empagliflozin on the fasting plasma glucose (FPG) concentration and β-cell function in subjects with impaired fasting glucose (IFG). Eight subjects with normal fasting glucose (NFG) and eight...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes
Auteurs principaux: Abdul-Ghani, Muhammad, Al Jobori, Hussein, Daniele, Giuseppe, Adams, John, Cersosimo, Eugenio, Triplitt, Curtis, DeFronzo, Ralph A.
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2017
Sujets:
Complications
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301341/
https://ncbi.nlm.nih.gov/pubmed/28611037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-0055
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires